Suspected lamotrigine-induced toxic epidermal necrolysis

Acta Neurologica Belgica

Volumn 103, Issue 2, 2003, Pages 95-98

  Söǧüt, Aysegül ^a   Yilmaz, Aynur ^a   Kilinç, Münire ^a   Söǧüt, Arif G ^a   Demiralay, Ebru ^a   Uzar, Hatice ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Ampicillin; Lamotrigine; Lyell's syndrome; Toxic epidermal necrolysis

Indexed keywords

AMPICILLIN; CARBAMAZEPINE; CEFUROXIME; CETIRIZINE; CLINDAMYCIN; COTRIMOXAZOLE; FANSIDAR; FLUCONAZOLE; LAMOTRIGINE; METHYLPREDNISOLONE; PREDNISOLONE; SULTAMICILLIN; VALPROIC ACID;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; CASE REPORT; CLINICAL FEATURE; ERYTHEMA MULTIFORME; FEMALE; FLUID THERAPY; HUMAN; LABORATORY TEST; NUTRITIONAL SUPPORT; PUNCH BIOPSY; SEIZURE; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; TONSIL DISEASE; TOXIC EPIDERMAL NECROLYSIS;

EID: 0037560033     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bouqet H., Farmer M., Bressieux J. M., Barzegar C., Jullien M., Soto B., Roujeau J. C., Revuz J. Toxic epidermal necrolysis and Steven-Johnson syndrome with lamotrigine. Annales de Dermatol. Venerol., 1999, 126 (1): 46-8.
2. Calabrese J. R., Sullivan J. R., Bowden C. L., Suppes T., Goldberg J. F., Sachs G. S., Shelton M. D., Goodwin F. K., Frye M. A., Kusumakar V. Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management. J. Clin. Psychiatry, 2002, 63 (11): 1012-9.
3. Chaffin J. J., Davis S. M. Suspected lamotrigine-induced toxic epidermal necrolysis. Ann. Pharmacother, 1997, 31: 720-723.
4. Chan H. L., Stern R. S., Arndt K. A., Langois J., Jick S. S., Jick H., Walker A. M. The incidence of erythema multiforme, Steven-Johnson syndrome, and toxic epidermal necrolysis. A population based study with particular reference to reactions caused by drugs among outpatients. Arch. Dermatol., 1990, 126 (1): 1103-4.
5. Faught E., Morris G., Jacobson M., French J., Harden C., Montouris G., Rosenfeld W., and PADS group. Adding lamotrigine to valproate: Incidence of rash and other adverse effects. Epilepsia, 1990, 40 (8): 1135-1140.
6. Forman R., Koren G., Shear N. H. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience. Drug Saf., 2002, 25 (13): 965-72.
7. Fernandez-Calvo C., Olascoago J., Resano A., Urcola J., Tuneu A., Zubizarreta J. Lyell syndrome associated with lamotrigine. Rev. Neurol., 2000, 32 (12): 1162-4 (abst).
8. Garcia-Doval I., LeCleach L., Boucquet H., Otero X. L., Roujeau J. C. Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death ? Arch. Dermatol., 2000, 136 (3): 323-7.
9. Kauppinen K., Stubb S. Drug eruptions: causative agents and clinical types. A series of inpatients during a 10 year period. Acta Derm. Venereol., 1984, 64 (4): 320-4.
10. Leach M. J., Marden C. M., Miller A. A. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II Neurochemical studies on the mechanism of action. Epilepsia, 1986, 27: 490-497.
11. Pevny I., Rockl H. Drug-induced allergic skin reactions of a cutaneous vascular type. MWM Munch. Med. Wochenschr, 1975, 117 (1): 9-16 (abst).
12. Robbens E. J., Schurges M. L., Boelaert J. R., Daneels R. F. Ampicillin induced acute interstitial nephritis and Lyell's syndrome. Acta Clin. Belg., 1985, 40 (2): 115-7.
13. Romano A., Di Fonso M., Pocobelli D., Giannarini L., Venuti A., Garcovich A. Two cases of toxic epidermal necrolysis caused by delayed hypersensitivity to beta-lactam antibiotics. J. Investig. Allergo Clin. Immunol., 1993, 3 (1): 53-5 (abst).
14. Roujeau J. C., Kelly J. P., Naldi M. S. L., Rzany B., Stern R. S., Anderson T. et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N. Eng. J. Med., 1995, 333: 1600-1608.
15. Rzany B., Correia O., Kelly J. P., Naldi L., Auquier A., Stern R. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study group of the International Case Control Study on Severe Cutanouse Adverse Reactions. Lancet, 1999, 353 (9171): 2190-4.
16. Sachs B., Rönnau A. C., Ruzicka T., Gleichmann E., Schuppe H. C. Lamotrigine and toxic epidermal necrolysis. Lancet, 1996, 348 (15): 1597.
17. Sachs B., Rönnau A. C., Schmiedeberg S., Ruzicka T., Gleichman E., Schuppe H. C. Lamotrigine-induced Stevens-Johnson Syndrome: Demonstration of specific lymphocyte reactivity in vitro. Dermatology, 1997, 195: 60-64.
18. Sadler M. Lamotrigine associated with insomnia. Epilepsia, 1999, 40 (3): 322-5.
19. Sane S. P., Bhatt A. D. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management. J. Assoc. Physicians India, 2000, 48 (10): 999-1003.
20. Scully M. C., Frieden I. J. Toxic epidermal necrolysis in early infancy. J. Am. Acad. Dermatol., 1992, 27 (2 Pt 2): 340-4.
21. Surbled M., Lejus C., Milpied B., Pannier M., Souron R. Lyell syndrome after amoxicillin administration in a 2 year old child. Ann. Fr. Anesth. Reanim., 1996, 15 (7): 1095-8 (abst).
22. Tagamai H., Tatsuda K., Iwatsi K., Yamada M. Delayed hypersensitivity in ampicillin-induced toxic epidermal necrolysis. Arch. Dermatol., 1983, 119 (11): 910-3.
23. Vucelic D., Bozinovic D., Tesovic I., Dobric I., Loncaric D., Knezovic I., Skerlev M. Lamotrigine and toxic epidermal necrolysis. Dermatology, 1997, 195: 307.
24. Wadelius M., Karlsson T., Wadelius C., Rane A. Lamotrigine and toxic epidermal necrolysis. Lancet, 1996, 348: 1041.
25. Yalçin B., Karaduman A. Stevens-Johnson syndrome associated with concomitant use of lamotrigine and valproic acid. J. Am. Acad. Dermatol., 2000, 43 (5 Pt 2): 898-9.